glp-1 drugs glycemic control mechanism Receptor Agonists as Treatments for Type 2 Diabetes Current Insights, Advantages and Challenges

and in July 2024, the FDA approved Kisunla (donanemab) for early symptomatic Alzheimers, based on evidence of reduced clinical decline and a limitedduration regimen tied to amyloid plaque removal

Here, a top obesity medicine physician explains everything you need to know about phentermine, including who might benefit most, who should avoid it and alternative medications to consider.

I'm pleased to share that npj Metabolic Health and Disease is joining Communications Medicine on a new collection looking at the Therapeutic Landscape of GLP1 agonists.

Microdosing GLP-1 for autoimmune disease may reduce inflammation and flares

Modern prescription weight loss medications: Wegovy, Ozempic, Mounjaro, Zepbound.

These incretin mimetic GLP-1 and GIP/GLP-1 drugs that help you lose body weight by slowing down